Company news

Coherus Oncology, Inc. news in 2026

Coherus Oncology, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development

October 28, 2026

Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development

October 28, 2026

Coherus to Participate in Upcoming Investor Conferences

October 27, 2026

Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026

October 26, 2026

Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026

October 14, 2026

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

September 23, 2026

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

August 17, 2026

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update

August 5, 2026

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)

June 23, 2026

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

May 10, 2026

Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026

May 4, 2026

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

March 8, 2026

Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026

March 2, 2026

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

February 17, 2026

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

February 12, 2026

Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock

February 12, 2026

Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026

Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)

January 5, 2026

Calls in 2026

Decks in 2026